BullishAgent BullishAgent Filings Economic Earnings Ratings IPOs Insiders Institutional ETFs Funds Screener
Sign in Register

SIGA

SIGA Technologies, Inc. NASDAQ Listed Sep 10, 1997
Healthcare ·Drug Manufacturers - Specialty & Generic ·US · siga.com
$4.72
After hrs $4.90 +2.08%
Mkt Cap $338.2M
52w Low $4.29 8.1% of range 52w High $9.62
50d MA $5.12 200d MA $6.84
P/E (TTM) 13.9x
EV/EBITDA 11.7x
P/B 1.7x
Debt/Equity 0.0x
ROE 11.7%
P/FCF 9.0x
RSI (14)
ATR (14)
Beta 1.06
50d MA $5.12
200d MA $6.84
Avg Volume 645.3K
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
SIC Code
2834
CIK (SEC)
Phone
212 672 9100
31 East 62nd Street · New York City, NY 10065 · US
Data updated apr 27, 2026 1:16am · Source: massive.com